ICSGlobal Ltd
ASX:ICS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
ICSGlobal Ltd
ASX:ICS
|
AU |
|
Heidrick & Struggles International Inc
NASDAQ:HSII
|
US |
|
Intrepid Potash Inc
NYSE:IPI
|
US |
|
Sensei Biotherapeutics Inc
NASDAQ:SNSE
|
US |
|
K
|
Kim Heng Ltd
SGX:5G2
|
SG |
|
Cosmo Energy Holdings Co Ltd
TSE:5021
|
JP |
|
U
|
United Palm Oil Industry PCL
SET:UPOIC
|
TH |
|
Northeast Securities Co Ltd
SZSE:000686
|
CN |
|
Physicians Realty Trust
NYSE:DOC
|
US |
|
N
|
Nexalin Technology Inc
NASDAQ:NXL
|
US |
|
TAL Education Group
NYSE:TAL
|
CN |
|
Domacom Australia Ltd
ASX:DCL
|
AU |
|
R
|
Royal Unibrew A/S
CSE:RBREW
|
DK |
|
CHAPTERS Group AG
XETRA:CHG
|
DE |
|
I
|
Isu Chemical Co Ltd
KRX:005950
|
KR |
|
Mettler-Toledo International Inc
NYSE:MTD
|
US |
|
Quince Therapeutics Inc
NASDAQ:QNCX
|
US |
|
S
|
Sicily By Car SpA
MIL:SBC
|
IT |
|
Southwestern Energy Co
NYSE:SWN
|
US |
|
Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO
|
US |
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
CN |
Balance Sheet
Balance Sheet Decomposition
ICSGlobal Ltd
ICSGlobal Ltd
Balance Sheet
ICSGlobal Ltd
| Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
2
|
3
|
2
|
2
|
3
|
3
|
5
|
23
|
4
|
|
| Cash Equivalents |
2
|
2
|
3
|
2
|
2
|
3
|
3
|
5
|
23
|
4
|
|
| Total Receivables |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Accounts Receivables |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
3
|
3
|
3
|
3
|
3
|
4
|
5
|
23
|
4
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Intangible Assets |
2
|
2
|
3
|
3
|
3
|
3
|
3
|
2
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Total Assets |
5
N/A
|
6
+16%
|
7
+23%
|
7
-4%
|
7
+0%
|
7
+11%
|
8
+10%
|
10
+21%
|
23
+139%
|
4
-85%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
1
|
1
|
2
|
3
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
2
|
1
|
1
|
1
|
2
|
3
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+67%
|
2
+54%
|
1
-48%
|
1
-3%
|
1
+63%
|
2
+32%
|
3
+78%
|
0
-95%
|
0
-79%
|
|
| Equity | |||||||||||
| Common Stock |
35
|
35
|
35
|
35
|
35
|
35
|
35
|
35
|
35
|
18
|
|
| Retained Earnings |
31
|
30
|
30
|
29
|
29
|
29
|
29
|
28
|
12
|
15
|
|
| Total Equity |
4
N/A
|
4
+7%
|
5
+16%
|
6
+10%
|
6
+1%
|
6
+3%
|
6
+5%
|
6
+3%
|
23
+263%
|
4
-85%
|
|
| Total Liabilities & Equity |
5
N/A
|
6
+16%
|
7
+23%
|
7
-4%
|
7
+0%
|
7
+11%
|
8
+10%
|
10
+21%
|
23
+139%
|
4
-85%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
10
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
|